Qualigen Therapeutics, Inc.
$3.21+5.59%(+$0.17)
TickerSpark Score
60/100
90
Valuation
20
Profitability
60
Growth
68
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QLGN research report →
52-Week Range22% of range
Low $1.61
Current $3.21
High $8.81
Companyqlgntx.com
Qualigen Therapeutics, Inc. , a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system.
- CEO
- Kevin A. Richardson II
- IPO
- 2015
- Employees
- 4
- HQ
- Carlsbad, CA, US
Price Chart
-36.97% · this period
Valuation
- Market Cap
- $5.43M
- P/E
- -0.49
- P/S
- 0.00
- P/B
- 0.45
- EV/EBITDA
- -0.03
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -94.09%
- ROIC
- -67.72%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-19,528,742 · -217.07%
- EPS
- $-8.11 · 53.07%
- Op Income
- $-13,202,096
- FCF YoY
- -9.86%
Performance & Tape
- 52W High
- $8.81
- 52W Low
- $1.61
- 50D MA
- $3.63
- 200D MA
- $3.20
- Beta
- 0.28
- Avg Volume
- 2.65M
Get TickerSpark's AI analysis on QLGN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 7, 24 | Bensler Graydon | other | 0 |
| Oct 8, 24 | Braeden Lichti | other | 0 |
| Jul 12, 24 | LIM ROBERT BRADLEY | other | 0 |
| Jul 12, 24 | BECHER CAMPBELL | other | 0 |
| Jul 12, 24 | PRICE CODY | other | 0 |
| Jul 11, 22 | Abdul-Ahad Wajdi | other | 80,000 |
| Jul 11, 22 | Lotz Christopher L. | other | 100,000 |
| Jul 11, 22 | Lotz Christopher L. | other | 100,000 |
| Jul 11, 22 | ARSHAD TARIQ | other | 102,000 |
| Jul 11, 22 | Ritter Ira E. | other | 40,000 |
Our QLGN Coverage
We haven't published any research on QLGN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QLGN Report →Similar Companies
SNGX+3.25%
Soligenix, Inc.
$0.39
OGEN+1.90%
Oragenics, Inc.
$0.58
TTNP-11.36%
Titan Pharmaceuticals, Inc.
$2.34
CANF+6.46%
Can-Fite BioPharma Ltd.
$3.46
XBIO-2.24%
Xenetic Biosciences, Inc.
$2.83
KZIA+7.37%
Kazia Therapeutics Limited
$12.97
ENSC+4.62%
Ensysce Biosciences, Inc.
$0.31
CNSP+6.69%
CNS Pharmaceuticals, Inc.
$5.10